These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18533207)

  • 1. [Oral bisphosphonates and CTX. New methods for assessing the degree of risk in maxillo-mandibular osteonecrosis].
    Blanc JL; Chossegros C
    Rev Stomatol Chir Maxillofac; 2008 Jun; 109(3):205-6. PubMed ID: 18533207
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    ; Khosla S; Burr D; Cauley J; Dempster DW; Ebeling PR; Felsenberg D; Gagel RF; Gilsanz V; Guise T; Koka S; McCauley LK; McGowan J; McKee MD; Mohla S; Pendrys DG; Raisz LG; Ruggiero SL; Shafer DM; Shum L; Silverman SL; Van Poznak CH; Watts N; Woo SB; Shane E
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1320-1; author reply 1321-2. PubMed ID: 18486811
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
    Tsai WS; Haghighi K; Placa SJ
    Gen Dent; 2006; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk?
    Assael LA
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2395-6. PubMed ID: 18022460
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaws.
    Throndson RR; Healy SM; Zwickey MR
    Tex Dent J; 2005 Sep; 122(9):960-5. PubMed ID: 16320503
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonates and bisphosphonate induced osteonecrosis.
    Sawatari Y; Marx RE
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):487-98, v-vi. PubMed ID: 18088900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTX and its role in managing patients exposed to oral bisphosphonates.
    Dodson TB
    J Oral Maxillofac Surg; 2010 Feb; 68(2):487-8; author reply 488-9. PubMed ID: 20116729
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kos M; Kuebler JF; Luczak K; Engelke W
    J Craniomaxillofac Surg; 2010 Jun; 38(4):255-9. PubMed ID: 19592261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maxillary osteonecrosis associated with bisphosphonates].
    Madrid C
    Rev Med Suisse; 2006 Nov; 2(86):2575-6. PubMed ID: 17168049
    [No Abstract]   [Full Text] [Related]  

  • 14. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of bisphosphonate-induced osteonecrosis of the jaw.
    Schilling J
    Northwest Dent; 2008; 87(3):34-5, 37-8, 40. PubMed ID: 18663869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sore mandible. Bisphosphonate-associated osteonecrosis.
    Damm DD; Fantasia JE
    Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonates and bone...what have we learned?
    Guttenberg SA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
    Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
    Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates, dental care and osteonecrosis of the jaws.
    Sitters MA; Caldwell CS
    Tex Dent J; 2005 Sep; 122(9):968-72. PubMed ID: 16320504
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws.
    Yeo AC; Lye KW; Poon CY
    Singapore Dent J; 2005 Dec; 27(1):36-40. PubMed ID: 16438267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.